
    
      Observational Objectives:

      To describe the safety of evaluated vaccine, in children aged ≥ 1th birthday and ≤ 12th
      birthday.

      To describe the immunogenicity of evaluated vaccine, in children aged ≥ 1th birthday and ≤
      12th birthday.
    
  